0.0000
-6.6000
(-100.00%)
As of September 23 at 8:16:48 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-29,792
-29,792
-17,932
-16,294
-19,487
Investing Cash Flow
-3,648
-3,648
-14
--
--
Financing Cash Flow
33,976
33,976
--
--
55,560
End Cash Position
21,338
21,338
20,821
38,757
55,070
Capital Expenditure
--
--
-14
--
--
Issuance of Capital Stock
33,976
33,976
--
--
55,041
Free Cash Flow
-29,792
-29,792
-17,946
-16,294
-19,487
12/31/2021 - 8/29/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
5IU.F Isofol Medical AB (publ)
0.1469
-2.07%
6DW.F D. Western Therapeutics Institute, Inc.
0.5750
+3.60%
2KZ0.F Kezar Life Sciences, Inc.
3.5000
-1.69%
3EE0.F Kancera AB (publ)
0.0838
-8.91%
2X10.DU Abivax SA
5.30
+2.91%
BTTAY Biotest Aktiengesellschaft
24.23
+6.27%
B1Q.F NRX Pharmaceuticals Inc. R
1.6300
+5.16%
0RU9.IL 0RU9.IL,0P0000KJ6A,0
1,147,190.00
0.00%
5LH0.F Guard Therapeutics International AB (publ)
1.0200
0.00%
6JU0.F BioCardia, Inc.
0.0000
-100.00%